Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim M Pabst

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Radiology|September 19, 2025
Evaluation of diffusion-weighted imaging datasets for the assessment of disease activity in lymphoma patientsJennifer Haferkamp, Michal-Kamil Chodyla, Aydin Demircioglu, et al.
Seminars in Nuclear Medicine|January 4, 2022
Clinical Use of PET/MR in Oncology: An UpdateRobert Seifert, David Kersting, Christoph Rischpler, et al.
Annals of Nuclear Medicine|October 17, 2025
Quantitative evaluation of <sup>123</sup>I-MIBG imaging in patients with myocarditis: impairment of cardiac neuronal function revisitedLukas Kessler, Stephan Settelmeier, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[<sup>18</sup>F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational StudyTimo Bartel, Kim M Pabst, Christina Barg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot studyKim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2023
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study)Kambiz Rahbar, Markus Essler, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2022
Safety and Survival Outcomes of <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior <sup>223</sup>Ra treatment: The RALU StudyKambiz Rahbar, Markus Essler, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PETAlina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 16, 2023
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the <sup>68</sup>Ga-FAPI PET Observational TrialLukas Kessler, Nader Hirmas, Kim M Pabst, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Radiology|September 19, 2025
Evaluation of diffusion-weighted imaging datasets for the assessment of disease activity in lymphoma patientsJennifer Haferkamp, Michal-Kamil Chodyla, Aydin Demircioglu, et al.
Seminars in Nuclear Medicine|January 4, 2022
Clinical Use of PET/MR in Oncology: An UpdateRobert Seifert, David Kersting, Christoph Rischpler, et al.
Annals of Nuclear Medicine|October 17, 2025
Quantitative evaluation of <sup>123</sup>I-MIBG imaging in patients with myocarditis: impairment of cardiac neuronal function revisitedLukas Kessler, Stephan Settelmeier, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[<sup>18</sup>F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational StudyTimo Bartel, Kim M Pabst, Christina Barg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot studyKim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2023
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study)Kambiz Rahbar, Markus Essler, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2022
Safety and Survival Outcomes of <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior <sup>223</sup>Ra treatment: The RALU StudyKambiz Rahbar, Markus Essler, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PETAlina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 16, 2023
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the <sup>68</sup>Ga-FAPI PET Observational TrialLukas Kessler, Nader Hirmas, Kim M Pabst, et al.
Pageof 4